The Cross-Industry Alliance on COVID-19 is making available a practical guide aiming at supporting industry and authorities to ensure sufficient supply of disinfectants to combat the COVID-19 pandemic.
In March 2020, at the initiative of Biocides for Europe (a sector group of Cefic), a Cross-Industry Alliance on COVID-19 was created together with A.I.S.E. (the International Association for Soaps, Detergents and Maintenance Products) and FECC (the European Association of Chemical Distributors). The main objective of the alliance is to provide industry with faster access to the relevant information, helping them to ensure that the authorities, medical facilities and the public all have enough supply of valuable disinfectants in this time of need.
Under the umbrella of the alliance, a practical guide has been developed with the voluntary contribution of CEHTRA (Consultancy for Environmental & Human Toxicology and Risk Assessment), and the law firms Fieldfisher (Belgium) LLP and Steptoe & Johnson LLP.
Practical Guide on Covid-19 Fast-Tracking Supply of Disinfectants
vs. 1.5 – updated on 25 January 2021
This guide aims to assist companies in complying with their obligations under the Biocidal Products Regulation (BPR) and equivalent national laws on biocides during the COVID-19 pandemic. The main part of this Practical Guide sets out the main procedures for fast-tracking the availability of disinfectants in order to help fight the pandemic.
This Practical Guide (and related appendixes) will no longer be updated from April 2022. Use of the information remains under the sole responsibility of the user. No liability is accepted with regard to the use that may be made of the information contained in this document.
Appendix 1 – Overview national measures to fast-track disinfectants
vs. 1.37 – 4 April 2022
Appendix 1 provides an overview of national measures (either under the Article 55 of BPR and/or national laws) that have been adopted in various European countries.
Appendix 2 – Active Substances PT1 and PT2
Appendix 2 lists all the active substances approved or under review for PT1 and PT2 at EU level. Further checks by companies with regards to the efficacy against encapsulated viruses, such as corona viruses should however be conducted.